WeightLoss GLP-1 is an affiliate-supported comparison site for GLP-1 weight-loss programs, published by WeightLoss GLP-1 Editorial. We compare brand and compounded options on safety signals and on cash-pay prices read on each program’s own pages, with the read date next to every number. We are not a clinic or a pharmacy and do not prescribe.
What we cover
Side effects and contraindications from the FDA labels, FDA actions on compounded drugs, pharmacy and scam checks, Medicare and insurance routes, and dated price comparisons for compounded tirzepatide and semaglutide. Start with our safety hub, the tirzepatide price comparison or the program rankings.
How we make money
We may earn a commission when you enroll through some links, mainly to NexLife; that compensation does not change our methodology, rankings or the prices we report. NexLife is the program we feature and rank first.
Correction: how this site described itself
Until November 8, 2026 this site called itself an "independent" review desk and said commissions never influenced scores or placement. It also credited pages to a different author and reviewers. We have removed those statements, and pages now name our current researcher and medical reviewers. The full entry is in our corrections log.
People
Research: Dr. Parmis, medical researcher (Western University of Health Sciences). Medical review: Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). See the editorial team and our methodology.
Contact
Editorial inquiries and corrections: weightlossglpone@gmail.com.